Candel Therapeutics adds biotech veteran Maha Radhakrishnan to Board

• click to rate

  Posted by Two Blokes Jun 6 - Filed in Stock - 2 views
  
  Candel Therapeutics Inc (NASDAQ:CADL) has appointed biotechnology industry veteran Maha Radhakrishnan, M.D., to its board of directors.